CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
- 4 Grant or award Director acquired 17,857 shares (grant or award)
- 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
- 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
- 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
- 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
- 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
- 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
- 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
- 4 Grant or award Director acquired 17,857 shares (grant or award)
- 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 1,156 shares at an average $37.69 ($43,573)
- 4 Open-market sale Director sold 968 shares at an average $41.97 ($40,632)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 5 of 18 · 354 filings